Navigation Links
Mathematical Model Can Now Help Predict Asthma Risk

A measure of how fast a person can exhale can now be used to predict the possibility of an asthma attack before a month using a mathematical tool. //It is believed that this finding would help alleviate the suffering of asthma patients and lead to the development of better treatment strategies.

An internationally accepted system called the chaos model (currently applied to complex systems such as weather) has been applied in the evaluation of lung function. Although the pattern examined seemed to have a random nature, there was a hidden periodicity in the peak flow pattern of 80 patients studied over a month. This enabled calculation of asthma risk accurately.

It is currently possible to calculate the risk only after sufficient data has been attained regarding the number of asthma attacks, following long hours of observation. With this model, this long period of waiting would be minimized as it eliminates the need for a positive asthma episode.

Furthermore, it has been found that the asthma attacks were highly variable and random in patients with severe asthma. One probable reason behind this observation could be hypersensitivity of the airways even to minor environmental stimulus such as pollutants or allergens.

Surprisingly, lung function instability has been noted in individuals who use inhaler for asthma relief. Infact, regular use of the inhaler can predispose to an acute episode. The risk was further aggravated due to use of short-acting bronchodilators or beta agonists. This finding is clinically relevant because the frequent use of inhaler only reflects the need for an effective asthma control.

"There are around 5.2 million asthmatics in the country and half of them have severe asthma requiring frequent use of inhalers. The numbers of children with asthma have increased six fold in the last 30 years and six to seven people will die of asthma every 24 hours. The cost to the NHS is enormous - close to
'"/>




Page: 1 2

Related medicine news :

1. Mathematical approach to asthma
2. Mathematical Model Predicts Cholera Outbreaks
3. Researchers Develop Mouse Model Of Brain Tumor
4. New Model for understanding Tumor Metastasis
5. Model Kate Moss - Re-Birth After Humiliation
6. Womens Self-Esteem Not Lowered By Seeing Ultra Thin Models
7. India Can Become A Role Model In Combating HIV Infections
8. Mouse Models To Determine The Cause Of Aggressive Leukemia
9. Aussie Model Macpherson Hated Tall Figure
10. Mouse Model Beneficial to Study of Head and Neck Cancer
11. Tamil Nadu Emerging As Model State In Public Health Care: Governor
Post Your Comments:
(Date:5/23/2012)... second edition of Law and the American Health Care ... 2012. Building on its 1997 predecessor, the second edition ... intersection of law and the U.S. health care system. ... a time of unprecedented change in how health care ... of study, the book focuses on how a dramatically ...
(Date:5/23/2012)... of the same kind, thereby triggering skeletal and cardiac ... from the RUB Heart and Diabetes Center NRW in ... an interdisciplinary research project with colleagues from the universities ... Journal of Biological Chemistry . , One ... stabilizing filaments inside of the cells. Different mutations in ...
(Date:5/23/2012)... FRANCISCO The number of viral infections during infancy ... to a new study from researchers in the Netherlands. ... later in childhood, this association was due in part ... in infancy, particularly rhinovirus, are thought to be a ... unclear whether this association is due to the viruses ...
(Date:5/23/2012)... present findings on prostate cancer risk, screening, treatment ... of the American Urological Association May 19-23 in ... to provide expert comment for reporters covering the ... presented and their embargo dates include: , ... surgery hormone therapy , Embargoed until 10:30 a.m. ...
(Date:5/22/2012)... MAYWOOD, Ill. -- Children born with cleft lip, ... medical challenges beyond appearance. , Patients can face ... well as social and psychological challenges, Laura Swibel ... colleagues write in the June 2012 issue of ... "The management of patients with craniofacial syndromes is ...
Breaking Medicine News(10 mins):Health News:Landmark textbook on health care and the US legal system released 2Health News:Aggregating instead of stabilizing: New insights into the mechanisms of heart disease 2Health News:Viral infections in infancy are not associated with wheezing symptoms in later childhood 2Health News:Mayo Clinic urologists present findings at American Urological Association Annual Meeting 2Health News:Mayo Clinic urologists present findings at American Urological Association Annual Meeting 3Health News:Mayo Clinic urologists present findings at American Urological Association Annual Meeting 4Health News:Cleft lip/palate cause much more than cosmetic problems 2
... enzyme which is discovered, may interpret the reasons for ... the UK) is known to relieve pain and fever, ... too and are known as non-steroidal anti-inflammatory agents (NSAIDs). ... cyclo-oxygenase (COX)-1 and COX-2. It is COX-2 which generates ...
... of Switzerland finds children who are exposed to greater levels ... or allergies. Researchers had parents of children ages 7 to ... also took blood samples from the kids to test for ... the children's bedding to test for levels of endotoxin, a ...
... irritability and dullness are common among people who have mild ... Cardiovascular Health Study is the largest ever investigation into heart ... 3,000 people in the US, some of who had a ... memory loss. ,Researchers at Wake Forest University now ...
... smokers have always been at a loss when it comes ... source of environmental tobacco smoke for residents. Environmental tobacco smoke// ... adverse health effects - from exacerbation of asthma to eye ... banned in the workplace and in public places. Researchers at ...
... study, researchers found that the treatment naltrexone is effective ... Researchers of alcohol often distinguish two patterns of drinking// ... are saved up for the weekend and holidays, and ... and often with meals. The Anglo-Saxon pattern has been ...
... a new study, children of people with mood disorders who ... their own lives as well. The link is especially strong ... women who suffer from mood disorders themselves. ,Research has ... increased risk of committing suicide, but few studies have looked ...
Other Medicine News:
(Date:5/22/2012)... Vanda Pharmaceuticals Inc. (NASDAQ: VNDA ), ... commercialization of products for central nervous system disorders, ... at the Society for Research on Biological Rhythms ... The first poster entitled Pleiomorphic Expression of ... insight into the challenges faced by individuals suffering ...
(Date:5/22/2012)... ALLEGAN, Mich., May 22, 2012  Perrigo Company ... final approval from the U.S. Food and Drug ... for butoconazole nitrate 2% vaginal cream, the generic ... submit a substantially complete ANDA with a paragraph ... marketing exclusivity. Perrigo is working exclusively with KV Pharmaceutical ...
(Date:5/22/2012)... Generics, a division of Prodigy Health Supplier Corporation ... generic equivalent of the branded drug Camptosar by ... Laboratories to develop a portfolio of oncology products. ... developed through the partnership that will add consistent ... market, which has experienced record levels of shortages ...
Breaking Medicine Technology:Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting 2Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting 3Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream 2Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream 3GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 1GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 2GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 3GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 4ULURU Inc Announces the Engagement of Gilford Securities Incorporated to Serve as the Companys Financial Advisor 18324 1ULURU Inc Announces the Engagement of Gilford Securities Incorporated to Serve as the Companys Financial Advisor 18324 2MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 1MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 2MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 3MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 4
... -- Additional Findings Reported Safety & Tolerability ... Healthy Subjects --, CHICAGO, June 25, 2007 ... at the annual meeting of the American ... (DPP-4) in development by Bristol-Myers,Squibb Company and ...
... WIRE)--Jun 27, 2007 - CytRx Corporation,(NASDAQ:CYTR), a ... of human therapeutics, today,announced promising data from ... IIa clinical trial with arimoclomol in ALS,volunteers. ... at a 100 mg dose three times ...
Other Medicine Technology:Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 2Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 3Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 4Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 5Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 6CytRx Reports Promising Data from Its Open-Label Extension Clinical,Trial of Arimoclomol in ALS 2CytRx Reports Promising Data from Its Open-Label Extension Clinical,Trial of Arimoclomol in ALS 3CytRx Reports Promising Data from Its Open-Label Extension Clinical,Trial of Arimoclomol in ALS 4CytRx Reports Promising Data from Its Open-Label Extension Clinical,Trial of Arimoclomol in ALS 5
... SPECIFICATIONS Form: Granular, free-flowing powder EEO (-m r ... 1.5C Remelt Point (1.5%): 88.0 1.5C ... 1,200 gm/cm 2 Gel Strength (1.5%): greater ... Moisture: less than or equal to 7% Turbidity ...
... ≤ 5000 mg/kg sulfate (SO 4 ) ≤ 5000 ... 5 mg/kg Co ≤ 5 mg/kg Cr ≤ 5 ... K ≤ 50 mg/kg Mg ≤ 5 mg/kg Mn ... 5 mg/kg Pb ≤ 5 mg/kg Zn ≤ 5 ...
... Application: Forms strong flexible gels ... ID clarifier: mixture of wide ... Solubility: water 10 mg/mL, clear, ... for molecular biology MP: 90 ...
Inquire...
Medicine Products: